Locally advanced or metastatic
WitrynaBackground: Variations in treatment choice, or late stage at first diagnosis, mean that, despite guideline recommendations, not all patients with hormone receptor (hr)–positive locally advanced or metastatic breast cancer (la/mbca) will have received endocrine therapy before disease progression. In the present study, we aimed to estimate the … Witryna11 kwi 2024 · In this two-part multicenter phase Ib study, eligible patients with locally advanced or metastatic NSCLC harboring c-MET overexpression or MET exon 14 …
Locally advanced or metastatic
Did you know?
Witryna30 wrz 2013 · Locally advanced unresectable disease represents around one third of the cases of pancreatic cancer at diagnosis. Although locally advanced pancreatic … Witryna1 dzień temu · “The 5-year survival rate for patients diagnosed with metastatic gastric cancer is estimated to be only 6%, and 80% of patients with locally advanced unresectable or metastatic gastric or GEJ ...
WitrynaThe disease status (metastatic/locally advanced, Eastern Cooperative Oncology Group performance status, tumor location, site of metastases, age, and sex) did not differ … WitrynaIntroduction. Rationale. Pancreatic adenocarcinomas are mostly at the advanced stage when diagnosed. The prognosis is poor, with a 5-year survival rate of around 8%. 1 …
WitrynaLBA73 - Study EV-103 Cohort K: Antitumor activity of enfortumab vedotin (EV) monotherapy or in combination with pembrolizumab (P) in previously untreated … Witryna9 kwi 2024 · However, most patients suffer from locally advanced or metastatic disease, where radical surgery cannot be performed ... were not able to undergo surgery because of their comorbidities. One hundred eighteen patients (70.2%) had locally advanced unresectable disease (stage III) at diagnosis; 18.5% (31/168) and 81.5% …
WitrynaThis study investigated the potency of anlotinib in treating locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma (RAIR-DTC). …
WitrynaLocally advanced or metastatic melanoma is probably turning from an orphan, medically optionless disease into a modern laboratory for clinical research, in which there is the possibility of successfully experimenting with the … manuals opel astra g engineWitryna24 lis 2024 · Background. Atezolizumab (atezo; anti–PD-L1) has proven efficacy in large global studies. To better understand the benefit of atezo in tumours that are highly … manuals panasonic microwaveWitrynaRandomisation was stratified by world region (USA vs western Europe vs or other), number of previous chemotherapy regimens for unresectable, locally advanced, or metastatic disease (0 or 1 vs >1), and disease involvement (visceral vs non-visceral). manual sorting in pivot tableWitrynaBackground: Variations in treatment choice, or late stage at first diagnosis, mean that, despite guideline recommendations, not all patients with hormone receptor … kpics ltdWitryna4 maj 2024 · Eligible patients were adults (≥18 years) with previously untreated locally advanced or metastatic non-small-cell lung cancer without a sensitising EGFR mutation or ALK translocation and with an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1, life expectancy 3 months or longer, and a PD-L1 … manual sortingWitryna1 lis 2007 · Evaluating the clinical effectiveness and cost-effectiveness of first-line chemotherapy currently licensed in Europe and recommended by NICE, for adult patients with locally advanced or metastatic non-small cell lung cancer found that cisplatin doublets are preferable to carboplatindoublets, but this is reversed if electronic market … kpi cross dockingWitrynaLocally advanced or metastatic melanoma is probably turning from an orphan, medically optionless disease into a modern laboratory for clinical research, in which … manual sort pivot chart